Lupin Ltd.
| BSE: 500257 | Sector: Health care |
| NSE: LUPIN | ISIN Code: INE326A01037 |
| BSE 00:00 | 16 Apr | 1055.85 |
6.10 (0.58%) |
OPEN
1061.80 |
HIGH
1069.00 |
LOW
1044.25 |
| NSE 00:00 | 16 Apr | 1055.85 |
5.80 (0.55%) |
OPEN
1054.00 |
HIGH
1069.15 |
LOW
1043.50 |
| OPEN | 1061.80 |
| PREVIOUS CLOSE | 1049.75 |
| VOLUME | 67040 |
| 52-Week high | 1121.85 |
| 52-Week low | 787.60 |
| P/E | 41.02 |
| Mkt Cap.(Rs cr) | 47,904 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
About Lupin Ltd.
Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations biotechnology products and active pharmaceutical ingredients (APIs) globally. The company is a significant player in the Cardiovascular Diabetology Asthma Pediatric CNS GI Anti-Infective and NSAID space and holds global leadership position in the Anti-TB segment....> More
Lupin Ltd - Key Fundamentals
| Parameter | Values | ||
| Market Cap | ( cr) |
47,904 | |
| EPS - TTM | () |
[*S] | 25.74 |
| P/E Ratio | (X) | [*S] | 41.02 |
| Face Value | () |
2 | |
| Latest Dividend | (%) | 300.00 | |
| Latest Dividend Date | 03 Aug 2020 | ||
| Dividend Yield | (%) | 0.57 | |
| Book Value / Share | () |
[*S] | 396.52 |
| P/B Ratio | () |
[*S] | 2.66 |
News
-
Titan, Lupin: How to trade dark horses in Rakesh Jhunjhunwala's portfolio
-
Trading tips by Ajit Mishra of Religare Broking: Buy Lupin, LIC Housing Fin
-
Nifty Pharma index surges 4%; Sun Pharma, Cipla hit 52-week highs
-
Lupin plans expansion, aims to enter Chinese market in the next one year
-
New product launches to drive growth for Lupin, US business a key trigger
Lupin Ltd - Financial Results
Particulars ( cr) |
Dec 2020 | Dec 2019 | % Chg |
| Net Sales | 4017.36 | 3769.27 | 6.58 |
| Other Income | 21.34 | 128.07 | -83.34 |
| Total Income | 4038.7 | 3897.34 | 3.63 |
| Total Expenses | 3238.62 | 3628.85 | -10.75 |
| Operating Profit | 800.08 | 268.49 | 197.99 |
| Net Profit | 441.35 | -840.36 | 152.52 |
| Equity Capital | 90.7 | 90.58 | - |
Lupin Ltd - Peer Group
| Company | Price() |
Chg (%) | Mkt Cap ( CR) |
| Aurobindo Pharma | 953.00 | 4.19 | 55836.27 |
| Cadila Health. | 527.00 | 4.56 | 53948.99 |
| Biocon | 412.80 | 2.05 | 49536.00 |
| Lupin | 1055.85 | 0.58 | 47903.91 |
| Torrent Pharma. | 2619.15 | 2.06 | 44321.26 |
| Gland Pharma | 2629.10 | 5.87 | 43012.08 |
| Piramal Enterp. | 1719.50 | 0.26 | 38783.32 |
Lupin Ltd - SHAREHOLDING PATTERN
|
|
|
Promoters
Banks/FIs
FIIs
Insurance
Mutual Funds
Indian Public
Custodians
OtherLupin Ltd - Research Reports
| Date | Broker | Action | Price | Report |
| 01/10/2020 | Prabhudas Lilladher | Buy | 1007 |  Details |
| 26/08/2020 | Prabhudas Lilladher | Buy | 970 | Details |
| 10/08/2020 | Emkay Global | Hold | 880 | Details |
| 11/05/2020 | Prabhudas Lilladher | Buy | 835 | Details |
Lupin Ltd - RETURNS
| Period | BSE | NSE | Sensex | NIFTY |
| 1 Week | -2.20% | -2.19% | -1.53% | -1.46% |
| 1 Month | 0.10% | 0.21% | -3.04% | -1.96% |
| 3 Month | -3.41% | -3.41% | -0.41% | 1.28% |
| 6 Month | 1.53% | 1.49% | 22.13% | 24.28% |
| 1 Year | 27.81% | 27.84% | 59.57% | 62.55% |
| 3 Year | 33.09% | 32.91% | 42.34% | 38.84% |
Lupin Ltd - STOCK STRENGTH
| Today's Low/High | 1044.25 |
|
1069.00 |
| Week Low/High | 1022.80 |
|
1100.00 |
| Month Low/High | 975.40 |
|
1100.00 |
| YEAR Low/High | 787.60 |
|
1122.00 |
| All TIME Low/High | 0.80 |
|
2127.00 |
Quick Links for Lupin:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
